Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Association between common iron store markers and hemoglobin in children with chronic kidney disease.

Atkinson MA, Pierce CB, Fadrowski JJ, Benador NM, White CT, Turman MA, Pan CG, Abraham AG, Warady BA, Furth SL.

Pediatr Nephrol. 2012 Dec;27(12):2275-83. doi: 10.1007/s00467-012-2266-x. Epub 2012 Jul 27.

2.

Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.

Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL.

Pediatr Nephrol. 2015 Apr;30(4):635-43. doi: 10.1007/s00467-014-2991-4. Epub 2014 Nov 8.

3.
4.

A 3-marker index improves the identification of iron disorders in CKD anaemia.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100606.

5.

Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.

Ogawa C, Tsuchiya K, Tomosugi N, Kanda F, Maeda K, Maeda T.

PLoS One. 2017 Jun 29;12(6):e0179608. doi: 10.1371/journal.pone.0179608. eCollection 2017.

6.

Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.

Kim IY, Kim JH, Lee DW, Lee SB, Rhee H, Song SH, Seong EY, Kwak IS.

Clin Exp Nephrol. 2018 Feb;22(1):28-34. doi: 10.1007/s10157-017-1409-6. Epub 2017 Apr 7.

PMID:
28389813
7.

Monitoring iron status in end-stage renal disease patients on hemodialysis.

Rafi A, Karkar A, Abdelrahman M.

Saudi J Kidney Dis Transpl. 2007 Mar;18(1):73-8.

8.

High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of U.S. adults.

Cheung CL, Cheung TT, Lam KS, Cheung BM.

Clin Nutr. 2013 Dec;32(6):1055-60. doi: 10.1016/j.clnu.2012.11.024. Epub 2012 Dec 28.

PMID:
23312547
9.

Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.

Davidkova S, Prestidge TD, Reed PW, Kara T, Wong W, Prestidge C.

Pediatr Nephrol. 2016 May;31(5):819-26. doi: 10.1007/s00467-015-3284-2. Epub 2015 Dec 14.

PMID:
26667237
10.

Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.

Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A.

Clin Nephrol. 2014 Jun;81(6):419-26. doi: 10.5414/CN108166.

PMID:
24691014
11.

Assessing iron status: beyond serum ferritin and transferrin saturation.

Wish JB.

Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S4-8. Review.

12.

Low levels of serum ferritin lead to adequate hemoglobin levels and good survival in hemodialysis patients.

Ogawa C, Tsuchiya K, Kanda F, Maeda T.

Am J Nephrol. 2014;40(6):561-70. doi: 10.1159/000370317. Epub 2015 Jan 10.

PMID:
25592750
13.

Iron deficient children and significance of serum ferritin.

Khan AS, Shah SA.

J Pak Med Assoc. 2005 Oct;55(10):420-3.

14.

A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.

Block GA, Fishbane S, Rodriguez M, Smits G, Shemesh S, Pergola PE, Wolf M, Chertow GM.

Am J Kidney Dis. 2015 May;65(5):728-36. doi: 10.1053/j.ajkd.2014.10.014. Epub 2014 Nov 4.

15.

[Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].

Chełchowska M, Laskowska-Klita T, Leibschang J.

Pol Merkur Lekarski. 2007 Jan;22(127):25-7. Polish.

PMID:
17477085
16.

Inter-Method Variability of Ferritin and Transferrin Saturation Measurement Methods in Patients on Hemodialysis.

Kamei D, Tsuchiya K, Miura H, Nitta K, Akiba T.

Ther Apher Dial. 2017 Feb;21(1):43-51. doi: 10.1111/1744-9987.12479. Epub 2016 Dec 13.

PMID:
27957820
17.

Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6. doi: 10.2215/CJN.05931108. Epub 2009 Apr 30.

18.

The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Jun 30;9(6):e99781. doi: 10.1371/journal.pone.0099781. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0123145. Mercadel, Lucile [corrected to Mercadal, Lucile].

19.

Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?

Dukkipati R, Kalantar-Zadeh K.

Nephrol News Issues. 2007 Jan;21(1):34-8. Review.

PMID:
17269263
20.

Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.

Uehata T, Tomosugi N, Shoji T, Sakaguchi Y, Suzuki A, Kaneko T, Okada N, Yamamoto R, Nagasawa Y, Kato K, Isaka Y, Rakugi H, Tsubakihara Y.

Nephrol Dial Transplant. 2012 Mar;27(3):1076-83. doi: 10.1093/ndt/gfr431. Epub 2011 Jul 28.

PMID:
21799206

Supplemental Content

Support Center